ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
ArQule Inc

ArQule Inc (ARQL)

20.00
0.00
(0.00%)
Al cierre: 04 Diciembre 3:00PM
20.00
0.00
( 0.00% )
Fuera de horario: -

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
20.00
Postura de Compra
19.99
Postura de Venta
19.50
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
20.00
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

ARQL Últimas noticias

Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm

Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm PR Newswire NEW YORK, Jan. 6, 2020 NEW YORK, Jan. 6, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities...

SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc. PR Newswire NEW YORK, Dec. 12, 2019 NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary...

ArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology...

- ARQ 531 demonstrates substantial anti-tumor activity and manageable safety profile - Eight of nine evaluable CLL patients initially dosed at ≥65 mg experienced a Partial Response (PR) - Five of...

(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price?

(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price? PR Newswire SAN DIEGO, Dec. 9, 2019 SAN DIEGO, Dec. 9, 2019 /PRNewswire/ -- Shareholder rights law...

Merck to Acquire ArQule, Advancing Leadership in Oncology

Acquisition Further Diversifies Merck’s Oncology Pipeline with Expansion into Targeted Therapies That Treat Hematological Malignancies Merck (NYSE: MRK), known as MSD outside the United States...

ArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual ...

Conference call and webcast with ArQule management to be held on Monday, December 9, 2019 at 8:15 a.m. EST ArQule management to hold an Investor Event on Monday, December 9, 2019 from 8:00-10:00...

ArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2019 in London...

ArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversi...

ARQ 531 demonstrates substantial anti-tumor activity in refractory CLL patients and manageable safety profile A total of 10 patients experienced partial responses (PRs) as of July 19th, the...

ArQule Reports Third Quarter 2019 Financial Results

Conference call scheduled today at 9:00 a.m. ET ArQule, Inc. (Nasdaq: ARQL) today announced its financial results for the third quarter of 2019. For the quarter ended September 30, 2019, the...

ArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Ther...

Data from a phase 1 clinical trial suggest that circulating tumor DNA (ctDNA) may serve as a reliable biomarker of tumor mutational status and could be used to predict treatment response...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CYCNCyclerion Therapeutics Inc
US$ 6.10
(278.88%)
141.52M
BLUEbluebird bio Inc
US$ 0.7396
(106.30%)
79.17M
SMXSMX Security Matters Public Company
US$ 0.381378
(95.78%)
826.25M
SRMSRM Entertainment Inc
US$ 1.15
(82.51%)
143.6M
CNEYCN Energy Group Inc
US$ 0.5349
(69.49%)
164.1M
RLMDRelmada Therapeutics Inc
US$ 0.6408
(-76.87%)
17.39M
MIGIMawson Infrastructure Group Inc
US$ 0.6885
(-63.95%)
23.17M
MONDMondee Holdings Inc
US$ 0.192
(-34.94%)
4.04M
ORISOriental Rise Holdings Ltd
US$ 8.02
(-32.89%)
663.79k
HTLMHomesToLife Ltd
US$ 3.10
(-27.57%)
162.81k
SMXSMX Security Matters Public Company
US$ 0.381378
(95.78%)
826.25M
SVMHSRIVARU Holding Ltd
US$ 0.023499
(6.81%)
475.14M
HTOOFusion Fuel Green PLC
US$ 0.5199
(63.49%)
279.76M
NVDANVIDIA Corporation
US$ 145.14
(3.48%)
231.12M
CNEYCN Energy Group Inc
US$ 0.5349
(69.49%)
164.1M

ARQL Discussion

Ver más
Tempy Tempy 5 años hace
Thanks...I got it as a recommendation from a guy I follow.
👍️0
DTGoody DTGoody 5 años hace
Wow! Awesome Job and Congratulations!! I love hearing stuff like this!
👍️0
Tempy Tempy 5 años hace
Good luck man...I didn’t buy options here. I bought for $9.00 a share and just wanted to see if a second bidder showed up.
👍️0
DTGoody DTGoody 5 años hace
I'm hoping there is a 2nd ARQL Bidder who is waiting until the last day to show his hand. Otherwise $20 will be the Deal and my calls will expire worthless. Either way this was nothing more than a lotto for me that has some potential on paying off Big if we get a 2nd offer? A month ago the calls were flying off the shelf and this did not look like retail to me. Good Luck to us.
👍️0
Tempy Tempy 5 años hace
You were right...the bid expires on January 15th at 11:59 pm. We have a few more trading days...
👍️0
DTGoody DTGoody 5 años hace
Hoping 2nd bidder emerges by next week as we are running out of time here. If I was the 2nd bidder I would wait until the last minute.
👍️0
Tempy Tempy 5 años hace
That would be amazing!!!
👍️0
DTGoody DTGoody 5 años hace
All I know is that I would love to see AQRL Halted for News and then see our new offer appear. I would be one happy camper! :)
👍️0
Tempy Tempy 5 años hace
I thought that might be right...I must have accidentally erased the email a couple weeks ago.
👍️0
DTGoody DTGoody 5 años hace
Not right off hand? Somebody had said they have until the 15th? Not sure if that is the date or not?
👍️0
Tempy Tempy 5 años hace
I received an email about selling or I would receive $20 for each share...I can’t find the email though. Do you remember the date we have to sell by?
👍️0
DTGoody DTGoody 5 años hace
Maybe if there is a 2nd bidder they are going to wait until the last minute to reveal themselves? They probably do not want to attract any other bidders. I followed the Big Money who bought a ton of calls in December signaling a 2nd ARQL Bidder behind the scenes. We shall see?
👍️0
DTGoody DTGoody 5 años hace
Come on 2nd Bidder Reveal yourself now! I would like to see that offer increased to at least $25. Merck is stealing ARQL for just $20.
👍️0
DTGoody DTGoody 5 años hace
ARQL Time to see the Bid Jump to $30 per share with a 2nd offer!
👍️0
NSX NSX 5 años hace
$ARQL...solid investment in 2019
👍️0
Tempy Tempy 5 años hace
Wow! Look at the action today...how high will she go?
👍️0
DTGoody DTGoody 5 años hace
$20.25
👍️0
MWM MWM 5 años hace
Ihub and big boards?

Try Twitter and Stocktwits...
👍️0
DTGoody DTGoody 5 años hace
I'm surprised with all that is going on with this nobody is on this board other than you and I? Big Board Stock Boards are like Ghost Towns! LOL :) ARQL looking Great today!
👍️0
DTGoody DTGoody 5 años hace
Volume is insane? What is going on here?
👍️0
DTGoody DTGoody 5 años hace
I Would love for this to be the week where ARQL gets a 2nd Bidder! Talk about an Amazing Christmas Gift! I have my Fingers, Toes, and everything else crossed here! Go ARQL!!!
👍️0
DTGoody DTGoody 5 años hace
I agree, and why I went heavy on the calls. This is crazy buying here!
👍️0
MWM MWM 5 años hace
I hope the guys buying all those calls are right about this! And the guys buying everything they can around $20!

This is Crazy!

👍️0
DTGoody DTGoody 5 años hace
God I hope you are right about this! :)
👍️0
hyder hyder 5 años hace
I am sure you are following elite...
Good luck
👍️0
MWM MWM 5 años hace
ARQL That Buyout offer is going to be higher soon imo!

👍️0
MWM MWM 5 años hace
ARQL very interesting...

👍️0
Couch Couch 5 años hace
Hedge fund arbitragers perhaps
👍️0
MWM MWM 5 años hace
Unusual Option Volume today

👍️0
MWM MWM 5 años hace
ARQL Rumor of a bidding war, Look at the April Calls!!!

I loaded all the $21 Calls I could get before they went Crazy!

👍️0
nferna nferna 5 años hace
do it again with APTO
👍️0
Couch Couch 5 años hace
Congrats on the entry point!! That is a sizable gain....I'm in at $6.98.......any thoughts on what you do with your shares moving forward?
👍️0
europtiger europtiger 5 años hace
Well done and congratulations again!!

👍️0
NSX NSX 5 años hace
$ARQL...been following their trial closely..

DD wins here

Make money

Invest wisely
👍️0
Tutu Tutu 5 años hace
If you wasn't in before today you missed the pop
👍️0
Tutu Tutu 5 años hace
Pop pop
👍️0
europtiger europtiger 5 años hace
Congrats !!!
👍️0
NSX NSX 5 años hace
$ARQL...I am holding a large position since $4.80. I am not missing a thing here..

Make money

Invest wisely
👍️0
Amikik Amikik 5 años hace
You are gonna miss lots of profits today , I think , Alas but more trading opportunities are here I think
👍️0
whytestocks whytestocks 5 años hace
$ARQL bears and bulls Arqule Inc Nasdaq Arql Short Squeeze
👍️0
ClayTrader ClayTrader 5 años hace
* * $ARQL Video Chart 11-27-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 años hace
* * $ARQL Video Chart 11-19-19 * *

Link to Video - click here to watch the technical chart video

👍️0
NSX NSX 5 años hace
$ARQL...back in early October when I posted that, many thought it was a typo.

Nope, it was not.

$ARQL sold my shares, but watching for another trend reversal
👍️0
ClayTrader ClayTrader 5 años hace
* * $ARQL Video Chart 11-12-19 * *

Link to Video - click here to watch the technical chart video

👍️0
NSX NSX 5 años hace
$ARQL....that last post explains our position here
👍️0
Firedog01890 Firedog01890 5 años hace
Ok just trying to get some perspective. Thanks!
👍️0
NSX NSX 5 años hace
$ARQL.....in apparent response to a just-released abstract on blood cancer candidate ARQ 531, a reversible BTK inhibitor, that will be presented at ASH next month.

https://ash.confex.com/ash/2019/webprogram/Paper127260.html

I believe people are comparing this BTK inhibitor Phase ! dosing and safety to Lilly more favorable safety profile

There is more there......for example a lower dose of 65 mg is now being tested and safer...more to follow

👍️0
Firedog01890 Firedog01890 5 años hace
Definitely not the only ones, any feel for why its dropping so much? News was pretty good, no insider trades etc.???
👍️0
NSX NSX 5 años hace
$ARQL- is Clay and I the only ones who know about $ARQL?

come on people-make some money!
👍️0
NSX NSX 5 años hace
$ARQL staying above $8.49 and breaking $8.79 is what I expect to see by EOW.

Bullish-enjoy
👍️0

Su Consulta Reciente

Delayed Upgrade Clock